King Loses Injunction Bid In Skelaxin Suit V. Sandoz
A federal judge has shot down a bid by King Pharmaceuticals Inc. to block Novartis AG generics unit Sandoz Inc. from making its own version of muscle relaxant Skelaxin....To view the full article, register now.
Already a subscriber? Click here to view full article